{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T21:07:50Z","timestamp":1772831270506,"version":"3.50.1"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bbrc.2025.152963","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T05:09:13Z","timestamp":1763183353000},"page":"152963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The development of an advanced lentiviral gene therapy for beta-thalassemia"],"prefix":"10.1016","volume":"793","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0222-5516","authenticated-orcid":false,"given":"Hongwei","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0497-0384","authenticated-orcid":false,"given":"Yingying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2395-5216","authenticated-orcid":false,"given":"Lung-Ji","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.152963_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.880752","article-title":"New insights into pathophysiology of \u03b2-Thalassemia","volume":"9","author":"Sanchez-Villalobos","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.bbrc.2025.152963_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-1172-5-11","article-title":"Beta-thalassemia","volume":"5","author":"Galanello","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbrc.2025.152963_bib3","article-title":"Thalassaemia international Federation guidelines for the management of transfusion-dependent thalassemia","volume":"6","author":"Farmakis","year":"2021","journal-title":"Hemasphere"},{"key":"10.1016\/j.bbrc.2025.152963_bib4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.hoc.2022.12.009","article-title":"Hematopoietic stem cell transplantation in thalassemia","volume":"37","author":"Algeri","year":"2023","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.bbrc.2025.152963_bib5","first-page":"364","article-title":"A new era for hemoglobinopathies: more than one curative option","volume":"17","author":"Psatha","year":"2017","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.bbrc.2025.152963_bib6","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1038\/sj.mt.6300259","article-title":"Improved human beta-globin expression from self-inactivating lentiviral vectors carrying the chicken hypersensitive site-4 (cHS4) insulator element","volume":"15","author":"Arumugam","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2025.152963_bib7","doi-asserted-by":"crossref","first-page":"10547","DOI":"10.1073\/pnas.0711666105","article-title":"In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of beta-thalassemia","volume":"105","author":"Miccio","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2025.152963_bib8","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1182\/blood-2003-04-1251","article-title":"Correction of a mouse model of sickle cell disease: lentiviral\/antisickling beta-globin gene transduction of unmobilized, purified hematopoietic stem cells","volume":"102","author":"Levasseur","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2025.152963_bib9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2174\/1566523214666141127095336","article-title":"Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of \u03b2-thalassemia and sickle cell disease","volume":"15","author":"Negre","year":"2015","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.bbrc.2025.152963_bib10","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1126\/science.1065806","article-title":"Correction of sickle cell disease in transgenic mouse models by gene therapy","volume":"294","author":"Pawliuk","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2025.152963_bib11","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1182\/blood-2002-10-3305","article-title":"A novel murine model of cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer","volume":"101","author":"Rivella","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2025.152963_bib12","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1182\/blood-2004-03-0863","article-title":"Extended beta-globin locus control region elements promote consistent therapeutic expression of a gamma-globin lentiviral vector in murine beta-thalassemia","volume":"104","author":"Hanawa","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2025.152963_bib13","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3390\/v15030713","article-title":"Gene therapy for \u03b2-Hemoglobinopathies: from discovery to clinical trials","volume":"15","author":"Segura","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.bbrc.2025.152963_bib14","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.hoc.2017.06.010","article-title":"Gene therapy approaches to hemoglobinopathies","volume":"31","author":"Ferrari","year":"2017","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.bbrc.2025.152963_bib15","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.hoc.2022.03.008","article-title":"Gene therapy for hemoglobinopathies: beta-thalassemia, sickle cell disease","volume":"36","author":"Leonard","year":"2022","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.bbrc.2025.152963_bib16","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41591-018-0301-6","article-title":"Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent \u00df-thalassemia","volume":"25","author":"Marktel","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2025.152963_bib17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/emmm.201000083","article-title":"Correction of beta-thalassemia major by gene transfer in haematopoietic progenitors of pediatric patients","volume":"2","author":"Roselli","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbrc.2025.152963_bib18","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1056\/NEJMoa1705342","article-title":"Gene therapy in patients with transfusion-dependent \u03b2-Thalassemia","volume":"378","author":"Thompson","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2025.152963_bib19","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.stem.2024.04.021","article-title":"Modified lentiviral globin gene therapy for pediatric \u03b2(0)\/\u03b2(0) transfusion-dependent \u03b2-thalassemia: a single-center, single-arm pilot trial","volume":"31","author":"Li","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbrc.2025.152963_bib20","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.bbmt.2014.07.016","article-title":"Outcomes of thalassemia patients undergoing hematopoietic stem cell transplantation by using a standard myeloablative versus a novel reduced-toxicity conditioning regimen according to a new risk stratification","volume":"20","author":"Anurathapan","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.bbrc.2025.152963_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00694339","article-title":"Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation","volume":"25","author":"Grochow","year":"1989","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.152963_bib22","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.bbmt.2018.06.013","article-title":"Risk score for the development of veno-occlusive disease after allogeneic hematopoietic cell transplant","volume":"24","author":"Strouse","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.bbrc.2025.152963_bib23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa2113206","article-title":"Betibeglogene autotemcel gene therapy for Non-\u03b2(0)\/\u03b2(0) Genotype \u03b2-Thalassemia","volume":"386","author":"Locatelli","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2025.152963_bib24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41591-021-01650-w","article-title":"Long-term outcomes of lentiviral gene therapy for the \u03b2-hemoglobinopathies: the HGB-205 trial","volume":"28","author":"Magrin","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2025.152963_bib25","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-Thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2025.152963_bib26","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1038\/s41591-022-01906-z","article-title":"CRISPR-Cas9-mediated gene editing of the BCL11A enhancer for pediatric \u03b2(0)\/\u03b2(0) transfusion-dependent \u03b2-thalassemia","volume":"28","author":"Fu","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2025.152963_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41591-021-01554-9","article-title":"Lentiviral globin gene therapy with reduced-intensity conditioning in adults with \u03b2-thalassemia: a phase 1 trial","volume":"28","author":"Boulad","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2025.152963_bib28","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1172\/JCI67930","article-title":"\u03b2-globin gene transfer to human bone marrow for sickle cell disease","volume":"123","author":"Romero","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2025.152963_bib29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ymthe.2019.09.020","article-title":"Improved titer and gene transfer by lentiviral vectors using novel, small \u03b2-Globin locus control region elements","volume":"28","author":"Morgan","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2025.152963_bib30","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1182\/blood-2007-08-108647","article-title":"Locus control region elements HS1 and HS4 enhance the therapeutic efficacy of globin gene transfer in beta-thalassemic mice","volume":"110","author":"Lisowski","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2025.152963_bib31","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1172\/JCI94378","article-title":"An erythroid-specific ATP2B4 enhancer mediates red blood cell hydration and malaria susceptibility","volume":"127","author":"Lessard","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2025.152963_bib32","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1182\/blood.V98.9.2664","article-title":"High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors","volume":"98","author":"Moreau-Gaudry","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2025.152963_bib33","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1182\/blood-2002-07-2211","article-title":"The degree of phenotypic correction of murine beta -thalassemia intermedia following lentiviral-mediated transfer of a human gamma-globin gene is influenced by chromosomal position effects and vector copy number","volume":"101","author":"Persons","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2025.152963_bib34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/hum.2007.173","article-title":"Optimization of recombinant adeno-associated viral vectors for human beta-globin gene transfer and transgene expression","volume":"19","author":"Maina","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bbrc.2025.152963_bib35","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1128\/jvi.58.3.921-936.1986","article-title":"Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis","volume":"58","author":"Shade","year":"1986","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2025.152963_bib36","doi-asserted-by":"crossref","first-page":"16798","DOI":"10.1074\/jbc.273.27.16798","article-title":"Identification and characterization of a conserved erythroid-specific enhancer located in intron 8 of the human 5-aminolevulinate synthase 2 gene","volume":"273","author":"Surinya","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.152963_bib37","doi-asserted-by":"crossref","first-page":"14669","DOI":"10.1073\/pnas.95.25.14669","article-title":"Derepression of human embryonic zeta-globin promoter by a locus-control region sequence","volume":"95","author":"Huang","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2025.152963_bib38","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1182\/blood.V86.3.1202.1202","article-title":"Targeted inactivation of the major positive regulatory element (HS-40) of the human alpha-globin gene locus","volume":"86","author":"Bernet","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2025.152963_bib39","first-page":"2057","article-title":"A single beta-globin locus control region element (5' hypersensitive site 2) is sufficient for developmental regulation of human globin genes in transgenic mice","volume":"12","author":"Morley","year":"1992","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2025.152963_bib40","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1073\/pnas.92.7.3014","article-title":"Retroviral transfer of a human beta-globin\/delta-globin hybrid gene linked to beta locus control region hypersensitive site 2 aimed at the gene therapy of sickle cell disease","volume":"92","author":"Takekoshi","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2025.152963_bib41","doi-asserted-by":"crossref","first-page":"11262","DOI":"10.1073\/pnas.90.23.11262","article-title":"Analysis of the human alpha-globin gene cluster in transgenic mice","volume":"90","author":"Sharpe","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2025.152963_bib42","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1093\/nar\/22.20.4139","article-title":"Analysis of a 70 kb segment of DNA containing the human zeta and alpha-globin genes linked to their regulatory element (HS-40) in transgenic mice","volume":"22","author":"Gourdon","year":"1994","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2025.152963_bib43","doi-asserted-by":"crossref","first-page":"8150","DOI":"10.1128\/JVI.72.10.8150-8157.1998","article-title":"Development of a self-inactivating lentivirus vector","volume":"72","author":"Miyoshi","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2025.152963_bib44","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/1566523013348634","article-title":"The molecular genetics of lentiviral vectors--current and future perspectives","volume":"1","author":"Chang","year":"2001","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.bbrc.2025.152963_bib45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.omtm.2016.11.002","article-title":"INSPIIRED: a pipeline for quantitative analysis of sites of new DNA integration in cellular genomes","volume":"4","author":"Sherman","year":"2017","journal-title":"Mol. Ther., Methods Clin. Dev."},{"key":"10.1016\/j.bbrc.2025.152963_bib46","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.exphem.2010.07.012","article-title":"Establishment of an erythroid cell line from primary CD36+ erythroid progenitor cells","volume":"38","author":"Wong","year":"2010","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bbrc.2025.152963_bib47","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1172\/JCI122836","article-title":"In vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia","volume":"129","author":"Wang","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2025.152963_bib48","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1172\/JCI200421838","article-title":"High-level beta-globin expression and preferred intragenic integration after lentiviral transduction of human cord blood stem cells","volume":"114","author":"Imren","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2025.152963_bib49","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1182\/blood-2010-01-263582","article-title":"Correction of murine \u03b2-thalassemia after minimal lentiviral gene transfer and homeostatic in vivo erythroid expansion","volume":"117","author":"Negre","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2025.152963_bib50","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1182\/blood.V99.6.1902","article-title":"Successful treatment of murine beta-thalassemia intermedia by transfer of the human beta-globin gene","volume":"99","author":"May","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2025.152963_bib51","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1182\/blood.V97.10.3275","article-title":"Functional requirements for phenotypic correction of murine beta-thalassemia: implications for human gene therapy","volume":"97","author":"Persons","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2025.152963_bib52","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/sj.bmt.1702151","article-title":"Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation","volume":"25","author":"Andreani","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbrc.2025.152963_bib53","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1182\/blood-2017-03-772392","article-title":"At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT","volume":"130","author":"Fitzhugh","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2025.152963_bib54","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1182\/blood.V90.9.3414","article-title":"Long-term transfer and expression of the human beta-globin gene in a mouse transplant model","volume":"90","author":"Raftopoulos","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2025.152963_bib55","doi-asserted-by":"crossref","DOI":"10.1177\/1559325820916572","article-title":"A comparison of Cs-137 \u03b3 rays and 320-kV X-Rays in a mouse bone marrow transplantation model","volume":"18","author":"Gott","year":"2020","journal-title":"Dose Response"},{"key":"10.1016\/j.bbrc.2025.152963_bib56","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.1068893","article-title":"Murine leukemia induced by retroviral gene marking","volume":"296","author":"Li","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2025.152963_bib57","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/gt.2013.67","article-title":"Evaluation of engraftment and immunological tolerance after reduced intensity conditioning in a rhesus hematopoietic stem cell gene therapy model","volume":"21","author":"Uchida","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.bbrc.2025.152963_bib58","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.exphem.2007.12.002","article-title":"A novel competitive repopulation strategy to quantitate engraftment of ex vivo manipulated murine marrow cells in submyeloablated hosts","volume":"36","author":"Wyss","year":"2008","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bbrc.2025.152963_bib59","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1182\/blood.V89.7.2268","article-title":"Enhanced host defense after gene transfer in the murine p47phox-deficient model of chronic granulomatous disease","volume":"89","author":"Mardiney","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2025.152963_bib60","first-page":"515","article-title":"Regimen-related toxicity in patients undergoing BMT with total body irradiation using a sweeping beam technique","volume":"10","author":"Cowen","year":"1992","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbrc.2025.152963_bib61","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1200\/JCO.1989.7.9.1288","article-title":"Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma","volume":"7","author":"Bearman","year":"1989","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2025.152963_bib62","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.bmt.1705733","article-title":"Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancy","volume":"40","author":"Saito","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbrc.2025.152963_bib63","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nbt1216","article-title":"Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration","volume":"24","author":"Montini","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbrc.2025.152963_bib64","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature09328","article-title":"Transfusion Independence and HMGA2 activation after gene therapy of human \u03b2-thalassaemia","volume":"467","author":"Cavazzana-Calvo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2025.152963_bib65","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2025.152963_bib66","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2025.152963_bib67","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients","volume":"118","author":"Howe","year":"2008","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2025.152963_bib68","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa2405541","article-title":"Hematologic cancer after gene therapy for cerebral adrenoleukodystrophy","volume":"391","author":"Duncan","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2025.152963_bib69","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa2109167","article-title":"Acute myeloid leukemia case after gene therapy for sickle cell disease","volume":"386","author":"Goyal","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2025.152963_bib70","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1182\/blood.2021011488","article-title":"Leukemia after gene therapy for sickle cell disease: insertional mutagenesis, busulfan, both, or neither","volume":"138","author":"Jones","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2025.152963_bib71","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ymthe.2024.12.028","article-title":"Balancing efficacy and safety in lentiviral vector-mediated hematopoietic stem cell gene therapy","volume":"33","author":"Montini","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2025.152963_bib72","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1182\/blood-2002-05-1409","article-title":"Deletion of the mouse alpha-globin regulatory element (HS -26) has an unexpectedly mild phenotype","volume":"100","author":"Anguita","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2025.152963_bib73","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S1097-2765(00)80144-6","article-title":"The beta-globin LCR is not necessary for an open chromatin structure or developmentally regulated transcription of the native mouse beta-globin locus","volume":"2","author":"Epner","year":"1998","journal-title":"Mol Cell"},{"key":"10.1016\/j.bbrc.2025.152963_bib74","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1182\/blood.V90.11.4602","article-title":"The human beta globin locus introduced by YAC transfer exhibits a specific and reproducible pattern of developmental regulation in transgenic mice","volume":"90","author":"Porcu","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2025.152963_bib75","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1182\/blood.V86.6.2419.bloodjournal8662419","article-title":"A second generation transgenic mouse model expressing both hemoglobin S (HbS) and HbS-Antilles results in increased phenotypic severity","volume":"86","author":"Fabry","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2025.152963_bib76","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.2772649","article-title":"Synthesis of functional human hemoglobin in transgenic mice","volume":"245","author":"Behringer","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2025.152963_bib77","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3109\/10731199409117905","article-title":"Chimeric hemoglobin subunits: functional properties of a recombinant beta\/alpha hemoglobin","volume":"22","author":"Dumoulin","year":"1994","journal-title":"Artif. Cells Blood Substit. Immobil. Biotechnol."},{"key":"10.1016\/j.bbrc.2025.152963_bib78","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/mthe.2002.0653","article-title":"Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes","volume":"6","author":"Nguyen","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2025.152963_bib79","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1182\/blood-2004-04-1427","article-title":"Successful correction of the human beta-thalassemia major phenotype using a lentiviral vector","volume":"104","author":"Puthenveetil","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2025.152963_bib80","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1525-0016(02)90720-3","article-title":"Molecular evidence of lentiviral vector-mediated gene transfer into human self-renewing, multi-potent, long-term NOD\/SCID repopulating hematopoietic cells","volume":"6","author":"Ailles","year":"2002","journal-title":"Mol. Ther."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25016791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25016791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T22:13:42Z","timestamp":1766096022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25016791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":80,"alternative-id":["S0006291X25016791"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152963","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The development of an advanced lentiviral gene therapy for beta-thalassemia","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152963","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152963"}}